Tinavi Medical Technologies Co Ltd
Tinavi Medical Technologies Co.,Ltd. engages in the research and development, production, sale, market, service, and clinical application of orthopedic surgery robots and related technologies. The company offers TiRobot II, an orthopedic robotic system to create an operation center; TiRobot, an orthopedic robotic system used in implants in surgery for spine and trauma; 5G remote surgery systems; … Read more
Tinavi Medical Technologies Co Ltd (688277) - Total Assets
Latest total assets as of September 2025: CN¥1.78 Billion CNY
Based on the latest financial reports, Tinavi Medical Technologies Co Ltd (688277) holds total assets worth CN¥1.78 Billion CNY as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Tinavi Medical Technologies Co Ltd - Total Assets Trend (2013–2024)
This chart illustrates how Tinavi Medical Technologies Co Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Tinavi Medical Technologies Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Tinavi Medical Technologies Co Ltd's total assets of CN¥1.78 Billion consist of 25.9% current assets and 74.1% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 15.4% |
| Accounts Receivable | CN¥81.30 Million | 4.8% |
| Inventory | CN¥31.67 Million | 1.9% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥45.17 Million | 2.7% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2013–2024)
This chart illustrates how Tinavi Medical Technologies Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Tinavi Medical Technologies Co Ltd's current assets represent 25.9% of total assets in 2024, a decrease from 69.9% in 2013.
- Cash Position: Cash and equivalents constituted 15.4% of total assets in 2024, up from 14.9% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, a decrease from 5.0% in 2013.
- Asset Diversification: The largest asset category is accounts receivable at 4.8% of total assets.
Tinavi Medical Technologies Co Ltd Competitors by Total Assets
Key competitors of Tinavi Medical Technologies Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Beijing Centergate Technologies Holding Co Ltd
SHE:000931
|
China | CN¥3.82 Billion |
|
Blue Sail Medical Co Ltd
SHE:002382
|
China | CN¥16.46 Billion |
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥28.98 Billion |
|
Allmed Medical Products Co Ltd Class A
SHE:002950
|
China | CN¥5.35 Billion |
|
Inix Technologies Holdings Bhd
KLSE:0094
|
Malaysia | RM72.53 Million |
|
Focus Point Holdings Bhd
KLSE:0157
|
Malaysia | RM328.19 Million |
|
Careplus Group Bhd
KLSE:0163
|
Malaysia | RM286.61 Million |
|
LKL International Bhd
KLSE:0182
|
Malaysia | RM173.46 Million |
Tinavi Medical Technologies Co Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Tinavi Medical Technologies Co Ltd generates 0.11x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Tinavi Medical Technologies Co Ltd is currently not profitable relative to its asset base.
Tinavi Medical Technologies Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.21 | 2.46 | 9.86 |
| Quick Ratio | 2.94 | 2.21 | 9.43 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥345.81 Million | CN¥ 192.78 Million | CN¥ 713.75 Million |
Tinavi Medical Technologies Co Ltd - Advanced Valuation Insights
This section examines the relationship between Tinavi Medical Technologies Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 8.86 |
| Latest Market Cap to Assets Ratio | 0.64 |
| Asset Growth Rate (YoY) | 4.5% |
| Total Assets | CN¥1.69 Billion |
| Market Capitalization | $1.09 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Tinavi Medical Technologies Co Ltd's assets below their book value (0.64 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Tinavi Medical Technologies Co Ltd's assets grew by 4.5% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Tinavi Medical Technologies Co Ltd (2013–2024)
The table below shows the annual total assets of Tinavi Medical Technologies Co Ltd from 2013 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥1.69 Billion | +4.46% |
| 2023-12-31 | CN¥1.62 Billion | +15.10% |
| 2022-12-31 | CN¥1.41 Billion | +10.00% |
| 2021-12-31 | CN¥1.28 Billion | +14.27% |
| 2020-12-31 | CN¥1.12 Billion | +56.85% |
| 2019-12-31 | CN¥713.60 Million | +7.69% |
| 2018-12-31 | CN¥662.66 Million | +6.42% |
| 2017-12-31 | CN¥622.67 Million | +235.17% |
| 2016-12-31 | CN¥185.77 Million | -12.36% |
| 2015-12-31 | CN¥211.96 Million | +215.95% |
| 2014-12-31 | CN¥67.09 Million | +62.19% |
| 2013-12-31 | CN¥41.36 Million | -- |